Comparison of four methods for pretreatment of cystic fibrosis sputa
Hoppe, J.E.; Holzwarth, J.; Stern, M.
European Journal of Clinical Microbiology and Infectious Diseases Official Publication of the European Society of Clinical Microbiology 15(11): 895-896
1996
ISSN/ISBN: 0934-9723 PMID: 8997569 DOI: 10.1007/bf01691228
Accession: 009799159
PDF emailed within 0-6 h: $19.90
Related References
Marshall, L.J.; Perks, B.; Bodey, K.; Suri, R.; Bush, A.; Shute, J.K. 2004: Free secretory component from cystic fibrosis sputa displays the cystic fibrosis glycosylation phenotype American Journal of Respiratory and Critical Care Medicine 169(3): 399-406Bradbury, R.S.; Tristram, S.G.; Roddam, L.F.; Reid, D.W.; Inglis, T.J.J.; Champion, A.C. 2011: Antimicrobial susceptibility testing of cystic fibrosis and non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa: a comparison of three methods British Journal of Biomedical Science 68(1): 1-4
Borgo, G.; Cappelletti, E.; Castellani, F.; Constantini, D.; Ferro, I.; Giunta, A.M.; Pederizini, F.; Mastella, G. 1981: The open question does cystic fibrosis new born screening and prophylactic treatment improve cystic fibrosis prognosis? comparison between cystic fibrosis patients birth diagnosed and cystic fibrosis patients much later diagnosed European Journal of Pediatrics 137(1): 120
Haas, B.; Kraut, J.; Marks, J.; Zanker, S.C.; Castignetti, D. 1991: Siderophore presence in sputa of cystic fibrosis patients Infection and Immunity 59(11): 3997-4000
Ben Dekhil, S.M.; Peel, M.M.; Lennox, V.A.; Stackebrandt, E.; Sly, L.I. 1997: Isolation of Lautropia mirabilis from sputa of a cystic fibrosis patient Journal of Clinical Microbiology 35(4): 1024-1026
Punch, G.; Syrmis, M.W.; Rose, B.R.; Harbour, C.; Bye, P.T.P.; Nissen, M.D.; Elkins, M.R.; Sloots, T.P. 2005: Method for detection of respiratory viruses in the sputa of patients with cystic fibrosis European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 24(1): 54-57
Kelly, N.; Clee, S.; Nakielna, B. 1995: Bioactive tumor necrosis factor in the sputa of cystic fibrosis patients Clinical and Diagnostic Laboratory Immunology 2(4): 499-502
Sadeghi, E.; Matlow, A.; MacLusky, I.; Karmali, M.A. 1994: Utility of gram stain in evaluation of sputa from patients with cystic fibrosis Journal of Clinical Microbiology 32(1): 54-58
Bauernfeind, A.; Bertele, R.M.; Harms, K.; Hörl, G.; Jungwirth, R.; Petermüller, C.; Przyklenk, B.; Weisslein-Pfister, C. 1987: Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis Infection 15(4): 270-277
Costello, C.M.; McQuaid, K.; O'Connor, C.M.; Fitzgerald, M.X. 1994: Effect of the addition of protease inhibitors to sputa from cystic fibrosis patients Biochemical Society Transactions 22(1): 53s
Hoppe, J.E.; Holzwarth, I.; Stern, M. 1997: Postal transport of sputa from cystic fibrosis patients does not decrease the microbiological yield Zentralblatt fuer Bakteriologie 286(4): 468-471
Chen, M.; Kondori, N.; Deng, S.; Gerrits van den Ende, A.H.G.; Lackner, M.; Liao, W.; de Hoog, G.S. 2018: Direct detection of Exophiala and Scedosporium species in sputa of patients with cystic fibrosis Medical Mycology 56(6): 695-702
Hoppe, J.E.; Holzwarth, I.; Stern, M. 1997: Postal transport of sputa from cystic fibrosis patients does not decrease the microbiological yield Zentralblatt für Bakteriologie: International Journal of Medical Microbiology 286(4): 468-471
Valenza, G.; Tappe, D.; Turnwald, D.; Frosch, M.; König, C.; Hebestreit, H.; Abele-Horn, M. 2008: Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society 7(2): 123-127
Laine, L.; Perry, J.D.; Lee, J.; Oliver, M.; James, A.L.; De La Foata, C.; Halimi, D.; Orenga, S.; Galloway, A.; Gould, F.K. 2009: A novel chromogenic medium for isolation of Pseudomonas aeruginosa from the sputa of cystic fibrosis patients Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society 8(2): 143-149
Bittar, F.; Richet, H.é; Dubus, J.-C.; Reynaud-Gaubert, M.; Stremler, N.; Sarles, J.; Raoult, D.; Rolain, J.-M. 2008: Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients Plos one 3(8): E2908
Flynn, J.M.; Cameron, L.C.; Wiggen, T.D.; Dunitz, J.M.; Harcombe, W.R.; Hunter, R.C. 2020: Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis Msphere 5(2)
Barthe, C.; Nandakumar, S.; Derlich, L.; Macey, J.; Bui, S.; Fayon, M.; Crouzet, M.; Garbay, B.; Vilain, S.; Costaglioli, P. 2015: Exploring the expression of Pseudomonas aeruginosa genes directly from sputa of cystic fibrosis patients Letters in Applied Microbiology 61(5): 423-428
Seale, T.; Tarpay, M.; Rennert, O. 1978: Heterogeneous antibiotic susceptibilities of pseudomonas aeruginosa from individual sputa of cystic fibrosis patients Clinical Research 26(6): 819A
Pages-Monteiro, L.; Marti, R.; Commun, C.; Alliot, N.; Bardel, C.; Meugnier, H.; Perouse-de-Montclos, M.; Reix, P.; Durieu, I.; Durupt, S.; Vandenesch, F.; Freney, J.; Cournoyer, B.; Doleans-Jordheim, A. 2017: Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa Plos one 12(3): E0173022